Outlook Therapeutics, Inc. (OTLK) Social Stream



Outlook Therapeutics, Inc. (OTLK): $1.37

0.10 (+7.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OTLK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Outlook Therapeutics Inc (OTLK) Price Targets From Analysts

Use the tables below to see what analysts covering Outlook Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $8 $6 $7 $1.57 345.86%

The Trend in the Analyst Price Target


OTLK's average price target has moved up $1.67 over the prior 118 days.

OTLK reports an average of 177.65% for its upside potential over the past 37 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-28 2 8 6.0 7.00 2.20 218.18%
2021-01-09 2 6 3.5 4.63 1.28 261.72%

OTLK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Outlook Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 96.73% of all US stocks.
  • OTLK has a higher number of analysts covering the stock than 6.73% of Pharmaceutical Products stocks.
  • Outlook Therapeutics Inc's average analyst price target is greater than 8.09% of all US stocks.
  • Outlook Therapeutics Inc's variance in analysts' estimates is lower than 67.8% of Pharmaceutical Products stocks.

Stocks similar to Outlook Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VTVT, LBPS and CAPR.

Is OTLK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5682 seconds.